August 4, 2020
Abiomed’s Impella Heart Pumps Receive FDA Emergency Use Authorization to Provide Unloading Therapy to COVID-19 Patients
August 4, 2020—Abiomed announced that the FDA has issued an emergency use authorization (EUA) for emergency use of the Impella left ventricular (LV) support systems.
Survival Rates With Abiomed's Impella Heart Pump Evaluated in Japanese Registry
July 30, 2020—Abiomed announced that a 3-year, investigator-led, prospective study of Japanese patients who received an Impella heart pump showed that use of the device is associated with a 77% survival rate at 30 days in acute myocardial infarction (AMI) cardiogenic shock patients.
GE Healthcare to Distribute Osprey Medical’s Contrast-Reduction Technology in Europe and Other Regions
July 30, 2020—GE Healthcare and Osprey Medical Inc. announced a strategic alliance under which GE Healthcare will exclusively distribute Osprey’s product portfolio in Europe, Russia, the Middle East, Africa, Central Asia, and Turkey.
Keystone Heart Launches TriGuard 3 Cerebral Embolic Protection Device in Europe
July 29, 2020—Keystone Heart, Ltd., a Venus Medtech company, announced the completion of the first commercial case using the TriGuard 3 cerebral embolic protection (CEP) device, which is designed to minimize the risk of cerebral damage during transcatheter heart procedures.
ACC’s New CardioSmart Website With COVID-19 Hub Provides Decision-Making Tools for Clinicians and Patients
July 28, 2020—The American College of Cardiology (ACC) announced the launch of the new CardioSmart website, the ACC’s patient engagement program that features shared decision-making tools and emphasizes the value of the patient and clinician partnership to personalize care.
Valve-in-Valve TAVR Compared With Redo SAVR in Study in France
July 27, 2020—In Journal of the American College of Cardiology (JACC), Pierre Deharo, MD, et al published findings from a study that analyzed the outcomes of valve-in-valve (VIV) transcatheter aortic valve replacement (TAVR) versus redo surgical aortic valve replacement (SAVR) at a nationwide level in France (2020;76:489-499).